Previous 10 | Next 10 |
Funding Enables Evaluation of PURION ® Processed Placental Tissue as an Innovative Approach in the Management of Acute Military-Related Injuries, Addressing a Critical Unmet Need MARIETTA, Ga., May 31, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIME...
Follows Previous Recommendation from Glass Lewis in Support of ALL Proposals Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends Shareholders Vote ...
Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends Shareholders Vote “FOR” the Company’s Say-on-Pay Proposal MARIETTA, Ga., May 20, ...
Decisive, Positive Actions Taken to Stabilize and Transform MIMEDX Have Established Strong, New Foundation for Growth Company Urges Shareholders to Vote “FOR” Both Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. –...
Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders PR Newswire Disappointed that the MiMedx Board Has Resorted to Disinformation and Distortions to Distract Shareholders from the Bo...
Highlights Successful Execution of Transformation Strategy Under CEO Tim Wright Reaffirms Commitment to Enhancing Value for ALL Shareholders Urges Shareholders to Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bier...
Cautions Shareholders Not to Let Prescience Point Unravel MIMEDX’s Transformation Urges Shareholders to Protect their Investments by Voting “FOR” Dr. Phyllis Gardner and James L. Bierman Highlights Prescience Point’s and Eiad Asbahi’s T...
Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group PR Newswire Intends on Withholding Votes Against Directors Phyllis Gardner and James Bierman at 2022 Annual Meeting and Vote Against Approval of Executive Compensation ...
MiMedx Group, Inc. (MDXG) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 AM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Officer Pete Carlson - Chief Financial Officer Rohit Kashyap - Executive Vice President and Chief Com...
MiMedx Group press release (NASDAQ:MDXG): Q1 GAAP EPS of -$0.11 misses by $0.01. Revenue of $58.89M (-1.4% Y/Y) beats by $4.79M. For further details see: MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M
News, Short Squeeze, Breakout and More Instantly...
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th most-cited journal in the world MARIET...
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 3...